Glenmark initiates multi-country Phase 3 clinical trial for Envafolimab in resectable Stage III NSCLC
The company has received approval from DCGI to begin patient enrolment and dosing in the country
The company has received approval from DCGI to begin patient enrolment and dosing in the country
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
Subscribe To Our Newsletter & Stay Updated